Abstract
Introduction The introduction of Corneal Crosslinking (CXL) in countries worldwide has led to a reduction in the need for corneal transplants in patients with keratoconus. This innovative and revolutionary procedure is relatively simple in concept, easy for patients to undergo, and can provide excellent outcomes in preserving and stabilizing vision. By stiffening the collagen fibers of the cornea, CXL can prevent progressive disease and vision loss. It is imperative for all eye care professionals to understand the positive long-term impact of this procedure and how it has become the standard of care in the management of selected keratoconus patients and those with other ectatic diseases. CE Notification This article is available as a COPE accredited CE course. You may take this course for 1-hour credit. Read the article and take the qualifying test to earn your credit. Please check COPE course expiry date prior to enrollment. The COPE course test must be taken before the course expiry date.